Compare GME & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GME | KRYS |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 9.3B |
| IPO Year | 2005 | 2017 |
| Metric | GME | KRYS |
|---|---|---|
| Price | $19.06 | $322.95 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | $13.50 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 5.1M | 609.9K |
| Earning Date | 06-09-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.33 | 128.00 |
| EPS | 0.66 | ★ 3.62 |
| Revenue | ★ $3,629,900,000.00 | $389,130,000.00 |
| Revenue This Year | $18.98 | $38.74 |
| Revenue Next Year | N/A | $32.53 |
| P/E Ratio | ★ $29.04 | $89.72 |
| Revenue Growth | N/A | ★ 33.94 |
| 52 Week Low | $18.55 | $132.31 |
| 52 Week High | $28.10 | $382.54 |
| Indicator | GME | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 29.54 | 42.23 |
| Support Level | N/A | $318.87 |
| Resistance Level | $22.41 | $377.89 |
| Average True Range (ATR) | 0.51 | 17.88 |
| MACD | -0.29 | -4.22 |
| Stochastic Oscillator | 17.90 | 35.27 |
GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.